Guinea-Bissau

KEY RESULTS - MALARIA

 

Reduction in malaria case incidence between 2000 and 2016

Source: World Health Organization

Antimalarial coverage by bed nets (2016)

Source: World Health Organization

Suspected cases of malaria tested (2016)

Source: World Health Organization

1.4 million insecticide treated bed nets distributed

Source: UNDP

More than a million mosquito nets distributed in a few short days

Between 31 May and June 4th 2017 the Ministry of Public Health, together with the Global Fund, UNDP as principal recipient and other partners, launched a national campaign for the distribution of Long-Lasting Insecticide-treated nets (LLINs) to protect more than 2 million children and adults from malaria, the leading cause of disease and death in Guinea-Bissau. It is proven that insecticide-treated mosquito nets can prevent 50 percent of malaria cases. With Global Fund support for the 2011 and 2014 net distribution campaigns, malaria prevalence dropped by 80 per cent, but remains a significant problem especially affecting children under 5 years of age.  The latest distribution means that over 2 million LLINs have now now been distributed.

Read the full story here

Project Summary

Guinea-Bissau has a population of 1.8 million. Malaria is endemic malaria and the leading cause of mortality nationally. Whilst malaria remains in the control phase, past activity has been successful in significantly reducing prevalence. The UNDP-managed Global Fund malaria programme has promoted the utilization of long lasting insecticide-treated bed nets (LLINs), and intermittent preventive treatment (ITP) for pregnant women following national protocols. The new round of funding (2018-2020) continues this work with the upscaling of prevention and treatment in the form of LLIN mass distribution, IPT, community based case management as well as the piloting of seasonal chemoprophylaxis. UNDP was nominated as principal recipient (PR) for the TB grant in May 2013, after the Global Fund’s review revealed programmatic challenges and financial irregularities, compounded by the 2012 coup d’état. After taking the role of PR, UNDP worked with partners to expand Directly Observed Treatment Short-course (DOTS) coverage and increase access to treatment for HIV/TB co-infected patients. The grant for TB has now been transferred to a national principal recipient.

KEY RESULTS - TB

 

5,000 TB cases detected and treated

Source: UNDP

561 TB patients recorded as HIV positive (2014)

Source: World Health Organization

79% treatment success rate for TB (2015)

Source: World Health Organization

Infant mortality

Source: World Health Organization

Maternal mortality

Source: World Health Organization

PORTFOLIO OVERVIEW

 

Disease Component

Malaria

Grant

GNB-M-UNDP

Phase

Period 2 (Jan 2018 - Dec 2020)

Amount

                        $16,127,192

Rating

 

Overall Grant Rating

 

 

  Exceeding expectations

 

  Meeting expectations

 

  Adequate

 

  Inadequate but potential demonstrated

 

  Unacceptable

 

  No rating available